Labor Pain Clinical Trial
Official title:
Effect of Manipulation of the Programmed Intermittent Bolus Time Interval and Injection Volume on Total Drug Use for Labor Epidural Analgesia: a Randomized Controlled Trial
Studies suggest that administration of maintenance epidural solutions as programmed or automated intermittent boluses, rather than continuous infusions, result in lower bupivacaine consumption, decreased need for manual boluses by the anesthesiologist, and greater patient satisfaction. In this technique, the epidural maintenance dose is administered as a bolus by the infusion pump at regular intervals instead of as a continuous infusion. However, the optimal combination of bolus volume and dosing interval has not been determined. At one end of the spectrum, a small volume and short bolus dose interval will likely behave like a continuous infusion. At the other end of the spectrum, a large volume and long bolus dose interval may lead to an increased incidence of breakthrough pain. The purpose of this randomized, double-blind trial was to determine how manipulation of the programmed intermittent time interval and volume influences total drug use, quality of analgesia, and patient satisfaction during maintenance of labor analgesia. We hypothesized that manipulation of the programmed intermittent bolus time interval and volume during the maintenance of epidural labor analgesia influences total drug use, quality of analgesia and patient satisfaction.
Traditionally, neuraxial labor analgesia was maintained for the duration of labor with
manual intermittent bolus injection of anesthetic by the anesthesiologist via an in-dwelling
epidural catheter. During the last decade, there has been a transition to maintenance of
analgesia with a continuous epidural infusion. Analgesia is maintained with fewer episodes
of breakthrough pain and parturient satisfaction is increased. The anesthesiologists'
workload is less. More recently, use of patient controlled epidural analgesia (PCEA) has
become popular; usually a continuous infusion is supplemented by patient-activated bolus
injections.
Studies have compared the intermittent manual epidural bolus technique to continuous
infusion, continuous infusion to PCEA without a background infusion, and PCEA with and
without a background infusion. Studies vary in the epidural solution local anesthetic mass
(volume and concentration), and lock-out intervals. The incidence and intensity of motor
blockade is greater with continuous infusion compared to bolus administration of the same
concentration/mass local anesthetic per unit time, whether the bolus is administered
manually or by PCEA. Consumption of local anesthetic is less with bolus administration
(manual or PCEA) compared to continuous infusion. Therefore, lower concentrations of local
anesthetic are frequently used for continuous infusions.
Current pump technology supports continuous epidural infusion, PCEA without a background
infusion, and PCEA with a background infusion. Current pump technology does not support
programmed intermittent bolus administration with or without supplemental PCEA. Further
study in this area may motivate pump manufacturers to redesign their pumps to support this
type of drug administration.
The purpose of the study is to determine how manipulation of the programmed intermittent
time interval and volume influences total drug use, quality of analgesia, and patient
satisfaction during maintenance of labor analgesia.
Eligible women were asked to participate shortly after admission to the Labor and Delivery
Unit at Prentice Women's Hospital immediately following the routine preanesthetic interview.
Informed, written consent was obtained. At the time of request for labor analgesia the
cervix was examined and a baseline Visual Analog Scale (VAS) for pain (100 mm unmarked line
with the end points labeled "no pain" and "worst pain imaginable") was determined. Labor
analgesia was initiated with a routine combined spinal epidural (CSE) technique. The VAS for
pain was determined 10 minutes after the intrathecal injection. If the VAS was less than 10
mm, the parturient was randomized (by a computer generated random number table) to one of
three programmed intermittent epidural bolus analgesia maintenance techniques: 2.5 mL every
15 minutes, 5 mL every 30 minutes, or 10 mL every 60 minutes. All epidural solutions
consisted of bupivacaine 0.0625% with fentanyl 1.95 micrograms/mL. The initial programmed
intermittent bolus dose was initiated 30 minutes after the intrathecal injection in all
groups.
Programmed intermittent epidural doses were administered via a Hospira Gemstar infusion
pump. A commercial pump that can be programmed to administer intermittent boluses and
patient controlled boluses does not exist. Thus two pumps were prepared for each subject
with the same epidural solution. One pump was programmed to administer the programmed
intermittent boluses at a rate of 300 ml/hr at regular intervals. The second pump was
programmed to administer the patient's controlled epidural analgesia.
VAS scores for pain were determined every 120 minutes until complete cervical dilation
beginning 60 minutes after the intrathecal injection. A modified Bromage score was
determined every 120 minutes during the 1st stage of labor (0=no motor paralysis;
1=inability to raise extended leg, but able to move knee and foot; 2=inability to raise
extended leg and to move knee, but able to move foot; 3=inability to raise extended leg or
to move knee and foot). Sensory threshold to a rigid von Frye filament (pressure applied
with the rigid tip until the subject reported feeling pressure at the thoracic dermatome of
T12, T10, T7, and T4) was determined bilaterally at initiation of epidural and 3 hours after
the intrathecal injection. Epidural infusion was discontinued shortly after delivery. Prior
to discharge from the Labor and Delivery Unit the parturient was asked to mark her overall
satisfaction with labor analgesia using a 100 mm unmarked line with the left end labeled
"not satisfied at all" and the right end labeled "extremely satisfied".
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03539562 -
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
|
||
Withdrawn |
NCT04662450 -
Evaluation and Management of Parturients' Pain Intensity
|
N/A | |
Completed |
NCT02885350 -
Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour
|
Phase 4 | |
Completed |
NCT02550262 -
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor
|
N/A | |
Completed |
NCT01598506 -
Intrathecal Hydromorphone for Labor Analgesia
|
Phase 2 | |
Withdrawn |
NCT01636999 -
Comparing Sedara to Butorphanol in Early Labor
|
N/A | |
Completed |
NCT00987441 -
Epidural Labor Analgesia and Infant Neurobehavior
|
N/A | |
Completed |
NCT00755092 -
Effect of Doula in Nulliparas and Multiparas
|
N/A | |
Terminated |
NCT00787176 -
The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes
|
N/A | |
Recruiting |
NCT06036797 -
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia
|
Phase 2 | |
Completed |
NCT05512065 -
Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women
|
N/A | |
Completed |
NCT05327088 -
Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia
|
Phase 2 | |
Completed |
NCT03103100 -
Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation
|
Phase 3 | |
Recruiting |
NCT03623256 -
Comparison of Intrathecal Versus Epidural Fentanyl on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia
|
Phase 4 | |
Active, not recruiting |
NCT02271100 -
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique
|
N/A | |
Completed |
NCT02926469 -
Virtual Reality Analgesia in Labor: The VRAIL Pilot Study
|
N/A | |
Completed |
NCT03712735 -
Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women
|
Phase 4 | |
Not yet recruiting |
NCT05565274 -
Outcome of Combined Tramadol and Paracetamol Versus Pentazocine as Labour Analgesia Among Parturients
|
N/A | |
Recruiting |
NCT02575677 -
Oxycodone in Treatment of Early Labour Pain Efficacy and Safety
|
||
Recruiting |
NCT01708668 -
The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
|
N/A |